Skip to content
10-Q

Quarterly Report

CONCENTRIX CORPORATION CNXC

0001803599-25-000106

← back to feed
Filed
Apr 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Mar 31, 2025 63.88M sh
Long Term Debt Q1 2025 · Feb 28, 2025 $4.9B
Long Term Debt Q1 2025 · Nov 30, 2024 $4.73B
Short Term Debt Q1 2025 · Feb 28, 2025 $460K
Short Term Debt Q1 2025 · Nov 30, 2024 $2.52M
Current Liabilities Q1 2025 · Feb 28, 2025 $1.79B
Current Liabilities Q1 2025 · Nov 30, 2024 $2B
Total Liabilities Q1 2025 · Feb 28, 2025 $7.86B
Total Liabilities Q1 2025 · Nov 30, 2024 $7.95B
Current Assets Q1 2025 · Feb 28, 2025 $2.96B
Current Assets Q1 2025 · Nov 30, 2024 $2.84B
Total Assets Q1 2025 · Feb 28, 2025 $11.9B
Total Assets Q1 2025 · Nov 30, 2024 $11.99B
Cash And Equivalents Q1 2025 · Nov 30, 2024 $240.57M
Shares Diluted Q1 2025 · Feb 29, 2024 65.79M sh
Stock Repurchased Q1 2025 · Feb 29, 2024 $21.67M
Dividends Paid Q1 2025 · Feb 29, 2024 $20.61M
Capex Q1 2025 · Feb 29, 2024 $56.06M
Operating Cash Flow Q1 2025 · Feb 29, 2024 −$46.87M
Stockholders Equity Q1 2025 · Feb 29, 2024 $4.1B
Stockholders Equity Q1 2025 · Nov 30, 2023 $4.14B
Eps Diluted Q1 2025 · Feb 29, 2024 $0.76
Eps Basic Q1 2025 · Feb 29, 2024 $0.76
Sga Expense Q1 2025 · Feb 29, 2024 $708.09M
Net Income Q1 2025 · Feb 29, 2024 $52.1M
Operating Income Q1 2025 · Feb 29, 2024 $148.44M
Gross Profit Q1 2025 · Feb 29, 2024 $856.53M
Cost Of Revenue Q1 2025 · Feb 29, 2024 $1.55B
Revenue Q1 2025 · Feb 29, 2024 $2.4B